Gamma Biosciences presented its portfolio of tech companies at Biotech Week Boston and spoke about its role as a disruptor in the consolidated bioprocess sector. “Gamma was built on this notion that advanced therapy manufacturing to date has largely been served by the biologics industry; the technologies that have been brute forced into our industry to make things work and get products to market,” Gamma Biosciences’ CTO Phil Vanek told BioProcess Insider at BPI East – part of Biotech Week…

Bioprocess giant Sartorius launched four products at Biotech Week Boston in September 2022. Miriam Monge, head of Marketing Fluid Management Technologies, walks us through them. First on display on the floor of the Boston Convention and Exhibition Center was Sartorius’ Celsius FFT, a large-volume bulk drug substance storage and transport system. According to Monge, such an offering is unique in its scale, and as a full platform, consisting of a blast freezer, a fill and drain station, a lift, a…

Miltenyi Biotec says it is uniquely placed in the advanced therapy space to support developers with the full gamut of technologies and chemical/biological substances. Founded in 1989, Miltenyi has moved from a cell separation firm into a full cell and gene services firm, offering a host of services including as a contract development and manufacturing organization (CDMO). “What makes Miltenyi unique is we not only supply the expertise from both the technological, biological and even regulatory expertise, but we have…

After acquiring Applikon Biotechnology in 2020, Getinge says it is focused on serving the bioprocess space as it does the medical tech industry. “Getinge has 90% of its business going into hospitals, like ventilators or operating rooms, but we also have a life sciences unit and we have acquired Applikon in January 2020 to become part of that business unit,” Matthijs Niemeijer, head of Product Management at Getinge told BioProcess Insider at BPI Boston, part of Biotech Week Boston. Applikon…

Chemical giant BASF says owning its own manufacturing facilities gives it full control of volume and chemistry and is a differentiator in the biopharma ingredients space. As the world’s largest chemical firm, it is no surprise BASF plays in numerous markets. In biopharma, the firm is known for its small molecule active pharmaceutical ingredient (API) business but the German multinational also serves the biologics manufacturing space. “For a few years we have been providing the biomanufacturing industry with our products…

Standardization is critical to improve fluid management operations within a biomanufacturing facility, says Cytiva at BPI Boston. “Fluid management, while it’s not one of the most technically complex parts of bioprocess, it’s one of the more logistically complex aspects,” Erik Storm, fluid management platform leader at Cytiva, told BioProcess Insider at BPI Boston – part of Biotech Week Boston. “That’s because of the large number of parts that you have to have on hand to actually run a single-use facility.…